Abstract
Huntington's disease (HD) is caused by a polyglutamine repeat in the protein huntingtin (Htt) with mutant Htt (mHtt) expressed throughout the body and similarly in all brain regions. Yet, HD neuropathology is largely restricted to the corpus striatum. We report that the small guanine nucleotide-binding protein Rhes, which is localized very selectively to the striatum, binds physiologically to mHtt. Using cultured cells, we found Rhes induces sumoylation of mHtt, which leads to cytotoxicity. Thus, Rhes-mHtt interactions can account for the localized neuropathology of HD.
Publication types
-
Research Support, N.I.H., Extramural
MeSH terms
-
Animals
-
Cell Death*
-
Cell Line
-
Cell Survival
-
Corpus Striatum / metabolism
-
GTP-Binding Proteins / metabolism*
-
Humans
-
Huntingtin Protein
-
Mice
-
Mice, Transgenic
-
Mutant Proteins / metabolism
-
Nerve Tissue Proteins / chemistry
-
Nerve Tissue Proteins / metabolism*
-
Nuclear Proteins / chemistry
-
Nuclear Proteins / metabolism*
-
PC12 Cells
-
RNA Interference
-
Rats
-
Recombinant Fusion Proteins / metabolism
-
SUMO-1 Protein / genetics
-
SUMO-1 Protein / metabolism
-
Small Ubiquitin-Related Modifier Proteins / metabolism
-
Substrate Specificity
Substances
-
HTT protein, human
-
Htt protein, mouse
-
Htt protein, rat
-
Huntingtin Protein
-
Mutant Proteins
-
Nerve Tissue Proteins
-
Nuclear Proteins
-
Recombinant Fusion Proteins
-
SUMO-1 Protein
-
SUMO1 protein, human
-
Small Ubiquitin-Related Modifier Proteins
-
GTP-Binding Proteins
-
Rasd2 protein, rat